INflammation-based Stratification for Immune-Targeted Augmentation in Major Depressive Disorder

NCT05644301 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

240

Enrollment

OTHER

Sponsor class

Conditions

Major Depressive Disorder
Inflammation

Interventions

DRUG: Celecoxib
DRUG: Minocyclin
DRUG: Placebo

Sponsor

Universiteit Antwerpen

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]